Adverse delivery hospitalisation outcomes in 2020 during the COVID-19 pandemic

BJOG. 2024 Jul;131(8):1111-1119. doi: 10.1111/1471-0528.17783. Epub 2024 Feb 20.

Abstract

Objective: To evaluate risk for adverse obstetric outcomes associated with the coronavirus disease 2019 (COVID-19) pandemic period and with COVID-19 diagnoses.

Design: Serial cross-sectional study.

Setting: A national sample of US delivery hospitalisations before (1/2016 to 2/2020) and during the first 10 months of (3/2020 to 12/2020) the COVID-19 pandemic.

Population: All 2016-2020 US delivery hospitalisations in the National Inpatient Sample.

Methods: Delivery hospitalisations were identified and stratified into pre-pandemic and pandemic periods and the likelihood of adverse obstetric outcomes was compared using logistic regression models with adjusted odds ratios (aOR) with 95% confidence intervals (CI) as measures of association. Risk for adverse outcomes was also analysed specifically for 2020 deliveries with a COVID-19 diagnosis.

Main outcome measure: Adverse maternal outcomes including respiratory complications and cardiac morbidity.

Results: Of an estimated 18.2 million deliveries, 2.9 million occurred during the pandemic. The proportion of delivery hospitalisations with a COVID-19 diagnosis increased from 0.1% in March 2020 to 3.1% in December. Comparing the pandemic period to the pre-pandemic period, there were higher adjusted odds of transfusion (aOR 1.12, 95% CI 1.05-1.19), a respiratory complication composite (aOR 1.37, 95% CI 1.29-1.46), cardiac severe maternal morbidity (aOR 1.30, 95% 1.20-1.39), postpartum haemorrhage (aOR 1.19, 95% CI 1.15-1.24), placental abruption/antepartum haemorrhage (OR 1.04, 95% CI 1.00-1.08), and hypertensive disorders of pregnancy (OR 1.23, 95% CI 1.21-1.26). These associations were similar to unadjusted analysis. Risk for these outcomes during the pandemic period was significantly higher in the presence of a COVID-19 diagnosis.

Conclusions: In a national estimate of delivery hospitalisations, the odds of cardiac and respiratory outcomes were higher in 2020 compared with 2016-2019. COVID-19 diagnoses were specifically associated with a range of serious complications.

Keywords: COVID‐19; maternal outcomes; severe maternal morbidity.

MeSH terms

  • Adult
  • COVID-19* / epidemiology
  • Cross-Sectional Studies
  • Delivery, Obstetric* / statistics & numerical data
  • Female
  • Hospitalization* / statistics & numerical data
  • Humans
  • Pandemics
  • Pregnancy
  • Pregnancy Complications, Infectious* / epidemiology
  • Pregnancy Complications, Infectious* / therapy
  • Pregnancy Outcome* / epidemiology
  • SARS-CoV-2*
  • United States / epidemiology
  • Young Adult